KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ClearPoint Neuro (CLPT) Debt to Equity (2018 - 2025)

ClearPoint Neuro's Debt to Equity history spans 12 years, with the latest figure at $1.84 for Q3 2025.

  • For Q3 2025, Debt to Equity changed N/A year-over-year to $1.84; the TTM value through Sep 2025 reached $1.84, changed N/A, while the annual FY2023 figure was $0.47, 75.2% up from the prior year.
  • Debt to Equity for Q3 2025 was $1.84 at ClearPoint Neuro, up from $1.46 in the prior quarter.
  • Across five years, Debt to Equity topped out at $1.84 in Q3 2025 and bottomed at $0.2 in Q4 2021.
  • The 4-year median for Debt to Equity is $0.41 (2021), against an average of $0.63.
  • The largest annual shift saw Debt to Equity tumbled 98.08% in 2021 before it soared 75.2% in 2023.
  • A 4-year view of Debt to Equity shows it stood at $0.2 in 2021, then skyrocketed by 33.0% to $0.27 in 2022, then skyrocketed by 75.2% to $0.47 in 2023, then soared by 291.51% to $1.84 in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Debt to Equity are $1.84 (Q3 2025), $1.46 (Q2 2025), and $0.47 (Q4 2023).